Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Lipids|May 1, 1993
Concentration-dependent effects of eicosapentaenoic acid on very low density lipoprotein secretion by the isolated perfused rat liverZ J Zhang, H G Wilcox, L Castellani, et al.Lipids|October 21, 1999
Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein compositionM B Elam, M A von Wronski, L Cagen, et al.Journal of Lipid Research|December 6, 2001
Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp ratM B Elam, H G Wilcox, L M Cagen, et al.American Heart Journal|September 30, 2000
Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT)C M Chesney, M B Elam, J A Herd, et al.JAMA|September 9, 2000
Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention TrialM B Elam, D B Hunninghake, K B Davis, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 1998
Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudicationM B Elam, J Heckman, J R Crouse, et al.Metabolism: Clinical and Experimental|July 17, 1998
Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytesM A von Wronski, K I Hirano, L M Cagen, et al.The American Journal of Cardiology|June 15, 1995
Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study GroupH B Rubins, S J Robins, D Collins, et al.The American Journal of Cardiology|January 1, 1993
Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterolH B Rubins, S J Robins, M K Iwane, et al.Metabolism: Clinical and Experimental|August 1, 1995
Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular diseaseT A Hughes, M B Elam, W B Applegate, et al.Pageof 3